Cargando…
MON-177 CAH-X Syndrome in a German Cohort of Patients with Congenital Adrenal Hyperplasia
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is encoded by the CYP21A2 gene. The CYP21A2 gene is flanked and partially overlapped by the TNXB gene encoding an extracellular matrix protein called Tenascin-X. Deficiency of Tenascin X can cause the Ehlers-Danlos Syndrome (EDS)....
Autores principales: | Sappl, Andrea, Lottspeich, Christian, Vill, Katharina, Morak, Monika, Bidlingmaier, Martin, Reisch, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207481/ http://dx.doi.org/10.1210/jendso/bvaa046.1671 |
Ejemplares similares
-
MON-170 Real World Estimates of Adrenal Insufficiency Related Adverse Events in Children with Congenital Adrenal Hyperplasia: On Behalf of the I-CAH Consortium
por: Ali, Salma R, et al.
Publicado: (2020) -
MON-175 Structural Instability as an Underlying Pathomechanism in Congenital Adrenal Hyperplasia
por: Meese, Nicolas, et al.
Publicado: (2020) -
Pitfalls of Prenatal Diagnosis guiding Postnatal Management in Congenital Adrenal Hyperplasia(CAH)
por: Murthy, Deepa Badrinath, et al.
Publicado: (2021) -
The Burden of Illness of Congenital Adrenal Hyperplasia (CAH) in Adults: Results: of a Structured Literature Review
por: Woods, Matthew Stephen, et al.
Publicado: (2021) -
RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)